Burning Rock Biotech (BNR) EBIAT (2020 - 2025)
Historic EBIAT for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to -$2.4 million.
- Burning Rock Biotech's EBIAT rose 5377.82% to -$2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$16.7 million, marking a year-over-year increase of 7198.71%. This contributed to the annual value of -$47.5 million for FY2024, which is 4842.02% up from last year.
- According to the latest figures from Q3 2025, Burning Rock Biotech's EBIAT is -$2.4 million, which was up 5377.82% from -$1.4 million recorded in Q2 2025.
- Burning Rock Biotech's EBIAT's 5-year high stood at -$1.4 million during Q2 2025, with a 5-year trough of -$41.2 million in Q1 2022.
- Moreover, its 5-year median value for EBIAT was -$24.0 million (2023), whereas its average is -$21.7 million.
- Its EBIAT has fluctuated over the past 5 years, first plummeted by 21366.21% in 2021, then skyrocketed by 9089.2% in 2025.
- Quarter analysis of 5 years shows Burning Rock Biotech's EBIAT stood at -$39.4 million in 2021, then grew by 20.45% to -$31.4 million in 2022, then rose by 27.12% to -$22.8 million in 2023, then skyrocketed by 51.26% to -$11.1 million in 2024, then skyrocketed by 78.85% to -$2.4 million in 2025.
- Its last three reported values are -$2.4 million in Q3 2025, -$1.4 million for Q2 2025, and -$1.9 million during Q1 2025.